Belite Bio 任命 Hendrik Scholl 为首席营销官，带来 20+ 年的医疗保健经验。 Belite Bio appoints Hendrik Scholl as CMO, bringing 20+ years of healthcare experience.

贝莱特生物任命亨德里克·肖尔为其新首席医疗官. Belite Bio has appointed Hendrik Scholl as its new Chief Medical Officer. 舒尔拥有超过20年的医疗保健经验,特别是在药物开发和监管事务方面,之前在阿斯特拉泽内卡担任过重要职务. Scholl brings over 20 years of healthcare experience, particularly in drug development and regulatory affairs, having previously held significant roles at AstraZeneca. 预计他的专业知识将增强贝利特生物的研发计划. His expertise is expected to enhance Belite Bio's research and development initiatives.